Skip to content

disease.nz

Your Daily Health News
Main navigation
Medical Editor February 9, 2022

FDA Approves Enjaymo for Treatment of Cold Agglutinin Disease – Pharmacy Times

FDA Approves Enjaymo for Treatment of Cold Agglutinin Disease  Pharmacy Times
Bookmark the permalink.

Recent Posts

  • Menopause may accelerate the progression of MS: Study – Multiple Sclerosis News Today
  • Hepatitis E vaccination is effective in an epidemic
  • The gap between living long and living healthy is growing – The Washington Post
  • Wrong place, wrong time: Why Zika virus hijacks a protein needed for brain growth
  • Camp Purple Live 2025: Celebrating A Decade Of Fun And Friendship For Kids And Teens With Inflammatory Bowel Disease – Scoop

Recent Comments

    Archives

    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
    Footer navigation
    • Privacy Policy